blotting and real-time PCR (CK7, CK8, CK20, Chr-A, pdx-1, shh, ptc). Results: Depending on three major morphologic phenotypes of tumor cell xenotransplants (ductal (YAPC), ductal/solid (DAN-G, CAPAN-1), solid (PANC-1, MIA PaCa-2)), a decrease of CK7/CK19 was found, accompanied by an increase of CK8/18 and vimentin. Predominantly the CK7-positive ductal phenotype (YAPC and DAN-G) was associated with pdx-1 expression, whereas the CK8-positive solid phenotype was associated with shh/ptc expression on protein and mRNA level. Additionally, CK-20 expression was mainly linked to the ductal phenotype, co-localized with nuclear ␤ -catenin.
Introduction
Pancreatic carcinoma is among the most aggressive solid malignancies, being the fi fth leading cause of cancer death in the Western world. Despite its rising incidence, little progress has been made in overall survival [1] .
The pancreas contains three different cell types: duct cells, exocrine cells and endocrine cells. Transition states of ductal and endocrine cells were observed during embryonic development [2] . Similar phenomena refl ecting these processes have been described during tumorigenesis of the pancreas [3] .
Newer concepts postulated that differentiation pathways, especially dedifferentation , recapitulating early stages of tissue morphogenesis and cell differentiation during pancreas ontogeny [4] [5] [6] , are key events in the initiation of tumorigenesis [7, 8] . This hypothesis is supported by the observation of re-expression of genes regulating embryonic pancreas development like sonic hedgehog pathway protein (shh) and its receptor Patched (ptc) [9, 10] as well as the pancreatic and duodenal homeobox gene 1 (pdx-1) [11, 12] in pancreatic adenocarcinoma and its precursor lesions of pancreatic intraepithelial neoplasia (PANINA). In part, dedifferentiation was detected by analyzing cytokeratin (CK) expression [13, 14] .
Phenomena of transdifferentiation that are associated with phenotype switches (e.g. from exocrine to ductal [15, 16] , exocrine to endocrine [17, 18] as well as from exocrine to mesenchymal [19, 20] and vice versa) are reported in pancreas tumorigenesis and reparation as well as in cell culture experiments. For the phenotype switches in transdifferentiation, it is postulated that cells must transiently dedifferentiate to a stem-cell-like phenotype linking de-and transdifferentiation pathways [21] . This is supported by the observation that transdifferentiation is linked with expression of the pancreatic duodenal homeobox-containing transcription factor pdx-1 [19, [22] [23] [24] . Furthermore, the process of trans-and dedifferentiation might be infl uenced by interactions with the environment, especially by laminins or ␤ -catenin, which are important mediators of epithelial-mesenchymal transitions and cell-cell adhesion as well as survival [25] [26] [27] [28] [29] .
Although these phenomena are specifi ed and have in part been investigated in vitro [20, 30] , systematical analyses using a xenograft model of human pancreatic cancer cells lines are still rare.
Therefore, the aim of our study was to investigate the possibility of differentiation pathways of human pancreatic cancer cell lines in vivo by a phenotype analysis using various specifi c markers of differentiation.
Material and Methods
Cell Culture YAPC, DAN-G, CAPAN-1, PANC-1 and MIA PaCa-2 pancreatic adenocarcinoma cells were cultured in RPMI-1640 medium (Biochrom, Berlin, Germany) containing 10% fetal bovine serum (Biochrom), penicillin (10 7 U/l, Biochrom) and streptomycin (10 mg/l, Biochrom) at 37 ° C and 5% CO 2 . YAPC, DAN-G and CAPAN-1 were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany) and PANC-1 and MIA PaCa-2 from the ATCC (Manassas, Va., USA), respectively.
In vitro Analysis
For in vitro assays, 150,000 cells were seeded per well of a 6-well culture plate (BD Biosciences, Heidelberg, Germany) or on chamber slides (Nunc, Wiesbaden, Germany) until confl uence.
Xenograft Model
Pancreatic carcinoma cell lines were harvested and resuspended in sterile physiologic NaCl solution. 3 ! 10 6 cells were injected subcutaneously into the fl ank of 4-to 6-week-old male NMRI mice (Harlan Winkelmann GmbH, Borchen, Germany). For each cell line, 5 animals were used. Animals were kept in a light-and temperature-controlled environment and provided with food and water ad libitum. Tumor size was determined daily by measurement with a caliper square. After 28 days, animals were sacrifi ced by cervical dislocation and specimens of tumor were either fi xed in 10% phosphate-buffered formalin or snap-frozen in liquid nitrogen. Ethical approval was achieved before the beginning of experiments.
Phenotypic Characterization of Pancreatic Cancer Cell Lines and Xenograft Specimens
Total protein was extracted from snap-frozen tumor samples, pooled from all animals of one group and subjected to SDS-PAGE as described previously [31] . Membranes were probed with the antibodies given in table 1 . Reactive bands were detected with the ECL chemiluminescence reagent (Amersham Pharmacia Biotech, Freiburg, Germany), digitized on a LAS-1000 luminescence image analyzer (Fuji Photo Film, Düsseldorf, Germany) and analyzed using GelScan 5 software (BioSciTec, Frankfurt, Germany).
Fixed and paraffi n-embedded tumor sections were subjected to routine hematoxylin and eosin (HE) staining and PAS reaction. Immunohistochemistry (IHC) was performed on pancreatic cancer cells xenografts as described [31] . Samples were analyzed with the antibodies given in table 1 . HE staining was used to evaluate basic histomorphology of the specimens, especially ductal and solid morphology which was assigned if the tumor displayed ductal and solid formations in 1 75% of the whole specimen. The epithelial mucopolysaccharides were detected by the PAS reaction.
To evaluate the extension of the IHC, the slides with the immunohistochemistical stainings were divided in quarters, digitized completely and analyzed quantitatively (% positive area) with the Ce2001 Cell Explorer software (BioSciTec). The intensity of the IHC staining was evaluated semiquantitatively (-= negative; ( ) = focally positive; + = weakly positive; ++ = positive; +++ = strongly positive). were added to get a total reaction volume of 10 l. The reaction was allowed to proceed for 50 min at 42 ° C, followed by 15 min at 70 ° C to inactivate the enzyme. After cDNA synthesis, distilled water was added to achieve a fi nal volume of 100 l in each sample.
RNA Isolation and Reverse Transcription

Quantitative Real-Time PCR
Primers were designed by use of the Primer Express software, Version 2.0.0 (Perkin-Ellmer Applied Biosystems, Foster City, Calif., USA). The sequences of primers are listed in table 2 . Each PCR assay was repeated three times for each cDNA sample. The 25 l total PCR volume consisted of 5 l cDNA, 12.5 l SYBRGreen PCR Master Mix (Applied Biosystems, Martinsried, Germany) and primers (MWG-Biotech, Ebersberg, Germany) in the following concentrations: 800 n M each for GAPDH and 400 n M each for the residual genes. After denaturation and activation of the hotstart enzyme for 10 min at 95 ° C, the PCR assays were carried out for 40 cycles, with denaturation at 95 ° C for 15 s, annealing and extension at 60 ° C for 1 min. To monitor amplifi cation of possible contaminated DNA, distilled water served as a negative control.
Fluorometric PCR was performed with the ABI Prism 7700 Sequence Detection System (Perkin-Elmer Applied Biosystems). After target amplifi cation, SYBRGreen specifi cally binds to doublestranded DNA, which leads to an increase in detectable fl uorescence signals. The amount of product detectable through fl uorescence signals at any given cycle within the exponential phase of PCR is proportional to the initial number of template copies. The number of PCR cycles needed to detect the amplicon is therefore a direct measure of the template concentration. Threshold cycle was set when emission intensity of measurable fl uorescence calibrated to starting level became equal to 10 standard deviations of the baseline.
Absolute quantifi cation was achieved through generation of standard curves using serial dilutions of known concentrations of the different cDNAs. The RT-PCR results were expressed as the ratio of molecules of target gene (e.g. CK7) per 1,000 molecules of housekeeping gene (GAPDH) normalized to the mean expression level of all fi ve cell lines. To monitor amplifi cation of genomic DNA due to pseudogenes, RNA aliquots without reverse transcription were always amplifi ed as negative controls.
Melting curve analysis was performed after each PCR run. After denaturation at 95 ° C for 20 s, a temperature ramp from 60 to 95 ° C in 20 min was run with simultaneous acquisition of fl uorescence signals. At the melting point of double-stranded PCR products, an accelerated decline of fl uorescence can be recognized. Using negative fi rst-deviation plots, we checked each sample for primer dimers and unspecifi c products due to mispriming. Furthermore, agarose gel electrophoresis of selected samples out of each PCR run was performed to check for unspecifi c amplifi cation products.
Results
Human Pancreatic Cancer Cell Line Xenografts in vivo
The tumor implants showed a continuous growth in all cases measured by planimetry. The mean tumor volume ( 8 SD) after 28 days as well as the Mib-1 proliferation rate (%) was (in increasing order): CAPAN-1 (364 8 148 mm (see table 3 , fi g. 1 ) CK7/CK19 and CK8/CK18 Profi le. The expression of typical pancreatic CKs (CK7/CK19 and CK8/CK18) and of the typical mesenchymal marker vimentin correlated with histological pattern and tumor grading. Typical ductal structures showed a strong expression of CK7/CK19, which was decreased in solid tumor formations, whereas CK8/CK18 was increased, accompanied by an increased expression of vimentin. Overall a clear zonal distribution of these CKs could not be observed. CK7/CK19 and CK8/CK18 were mainly found in the periphery of DAN-G and PANC-1 xenografts. An association between tumor cell morphology and expression of CK7/CK19 as well as CK8/CK18 could not be established. Expression of Transdifferentiation Markers. CK20 expression was mainly found in tumor xenografts with ductal differentiation (YAPC) or mixed ductal and solid structures (DAN-G and CAPAN-1). In these cases a predominant peripheral location of CK20 expression was found and was associated with a tubulus-like phenotype of ductal tumor formation (CAPAN-1) which mimicked PANINA.
Immunophenotype of Xenografts
␤ -Catenin was diffusely localized at the cytoplasm membrane in the xenografts of YAPC, DAN-G and CAPAN-1. Focally, a nuclear expression of ␤ -catenin, colocalized with the expression of CK20, was also observed of protein and mRNA were found in tumors with a ductal or ductal/solid phenotype. Comparable to the IHC results, the loss of morphologic differentiation was associated with increased levels of CK8. The expression levels of CK7 and CK8 were associated with the mRNA levels of dedifferentiation parameters: In cases with high amount of pdx-1 (YAPC and DAN-G) higher levels of CK7 and lower levels of CK8 and shh/ptc than in all other cancer cell lines were detected. Protein and mRNA levels of CK20 were associated with pdx-1 and CK7-expression. Finally, low levels of Chr-A protein were detectable in DAN-G, PANC-1 and CAPAN-1 while MIA PaCa-2 showed high levels of Chr-A mRNA (data not shown) and protein.
Human Pancreatic Cancer Cell Lines in vitro (see fi g. 2 A, C, 3 B )
Pancreatic carcinoma cell lines express the classical ductal human pancreatic cancer CK pattern profi le (CK7/ CK19 and/or CK8/CK18) in vitro as proven by immunocytochemistry (data not shown), Western blotting and mRNA analysis. In detail, expression of CK7 in combination with CK8 was found in YAPC, DAN-G and CAPAN-1, whereas CK8 was only detected in PANC-1 and MIA PaCa-2 pancreatic cancer cell lines. Expression of markers of trans-and dedifferentiation (Chr-A, pdx-1 and ptc) was only marginally detectable in PANC-1 and MIA PaCa-2 cell lines. Expression of CK20 (determined by Western blot and mRNA analysis) was only faintly seen in YAPC. Interestingly, these results were not paralleled for DAN-G and PANC-1 on mRNA levels regarding CK20 and shh.
Comparison of Protein and mRNA Expression in vitro and in vivo
The typical CK profi le of human pancreas could be detected in vitro and in vivo. In contrast to in vitro experiments, PANC-1 and MIA PaCa-2 show a novel expression of CK7, a marker of ductal differentiation, in vivo.
Although focal expression of markers of trans-and dedifferentiation could already be observed in vitro. These phenomena were more enhanced on protein level in all human pancreatic cancer cell line xenografts, especially for CK20 (YAPC, DAN-G, CAPAN-1, MIA PaCa-2), Chr-A (all), pdx-1 (YAPC, DAN-G, PANC-1), shh (PANC-1 and MIA PaCa-2) and ptc (all except CAPAN-1). Although single genes were overexpressed in vivo (e.g. CK20 in YAPC, pdx-1 in YAPC and DAN-G, shh and ptc in MIA PaCa-2), the overall expression pattern of mRNA was heterogeneous between in vitro and in vivo experiments.
Discussion
In this model of human pancreatic carcinoma xenografts in nude mice, we demonstrated that different human ductal pancreatic carcinoma cell lines exhibit distinct morphological patterns and molecular markers of trans-and dedifferentiation. In detail, we detected two major specialized morphologic and molecular pathways inside different human ductal pancreatic carcinoma cell lines: (i) a ductal tumor pattern (YAPC and DAN-G) with predominance of CK7 and pdx-1 and (ii) a more dedifferentiated solid tumor pattern (CAPAN-1, MIA PaCa-2 and PANC-1) with increased expression of CK8 and shh/ ptc. These fi ndings are of special interest as they indicate that xenografts of human pancreatic tumor cell lines have the potency to express markers known in embryonic pancreatic development, showing that these cell lines can reactivate otherwise inactive signaling pathways of development.
Embryologic development of the pancreas is under control of several homeodomain box proteins [for detailed reviews, see [4] [5] [6] : Among these, members of the sonic hedgehog protein family (shh) and their cognate receptors, Patched (ptc), are involved in pancreatic morphogenesis, regulating the formation of the dorsal and ventral endodermal buds with later fusion [32] [33] [34] . Additionally, ductal and endocrine differentiations arise from exocrine parts of the embryonic pancreas and are controlled by the pancreas duodenum homeodomain protein pdx-1, which is expressed in the whole pancreas in early embryonic development but is only found in ␤ -cells of endocrine islets in the adult pancreas [35, 36] .
Additionally, shh and pdx-1 are also upregulated in pancreatic tumorigenesis [9, 12] , while the functional significance of this is so far unknown. There is some evidence that shh and pdx-1 act contrary in some circumstances (amniote embryo) [37] , while we and others observed synergistic regulation of shh and pdx-1 on the protein level in mature pancreas (at least in mammals) [38] and in zebrafi sh embryo [39] . Ductal alterations preceding carcinoma formation, so-called PANINA, are spatiotemporally regulated by differential expression of shh [10] and pdx-1 [11] . In concordance with our observations, recent investigations on epithelial intermediate fi lament proteins demonstrated that dedifferentiation is associated with different expression of CKs [13, 14] .
Interestingly, we found that these factors of embryologic development (pdx-1 and shh/ptc) as well as the CK profi le are associated with morphological signs and protein expression patterns of transdifferentiation. A tubular transdifferentiation with enhanced expression of CK20 was observed in the ductal group [40, 41] . This was associated with an increased expression of ␤ -catenin in well-differentiated human carcinoma cell lines. Additionally, we confi rmed the fi ndings of Joo et al. [28] and Qiao et al. [29] that grading of pancreas cancer is associated with reduced membranous and cytoplasmatic expression of ␤ -catenin. Expression of vimentin, a classical marker of mesenchymal differentiation, was mainly observed in dedifferentiated human carcinoma cell lines like MIA PaCa-2, which corroborates earlier fi ndings [13, 20] . Furthermore, the vimentin-positive cell lines PANC-1 and MIA PaCa-2 showed a reduced expression of pdx-1 and elevated levels of ptc which is in line with the current literature [19] . These cell lines also displayed a higher expression of ␣ 1 -chym indicating a true acinar transdifferentiation. Endocrine transdifferentiation was observed at low levels in all human pancreas carcinoma cell lines, indicating that this is not limited to the known pdx-1 ductal pathway [22, 23] .
In particular, expression of molecular markers of transand dedifferentiation were more pronounced in a physiologic environment compared to cell culture conditions.
The observed overexpression of laminin-5 at the tumor border confi rmed that epithelial-mesenchymal interactions are essentially involved in the tumor progression, also in pancreatic cancer [26] .
Overall, growing evidence suggests that tumorigenesis repeats embryologic development pathways in many aspects: Neoplastic cells re-or dedifferentiate into a stemcell-like phenotype with the potential of proliferation [25, 27] . One of the best examples in this fi eld is the adenocarcinoma of the colon. Intensive morphologic analyses of colon tumors showed that tumor formation imitates typical morphological patterns of budding and branching during embryogenesis which was confi rmed by molecular analyses [42] . Additional studies of gastric carcinomas showed that neoplastic changes in the gastric cancer sequence are associated with dedifferentiation imitating fetal morphogenesis [43] , indicating that these mechanisms are commonly found in gastrointestinal tumor development and might also apply to pancreatic carcinogenesis.
According to our study design, we are aware that this is a relatively static glance at the differentiation potential of the various human pancreatic cancer cell lines in a nude mouse xenograft model, regardless of immediate changes after xenografting due to technical reasons (injection of tumor cell suspension).
In summary, the observed fi ndings indicate that (i) human pancreatic cancer cell lines have the complete potential for differentiation in vivo, (ii) imitating different stages of embryonic pancreatic development, (iii) which could possibly be used further as a tool for designing specifi c tumor therapies.
